US Patent 7732613 Met kinase inhibitors

Patent 7732613 was granted and assigned to Bristol-Myers Squibb on June, 2010 by the United States Patent and Trademark Office.

Is a

Current Assignee

Patent Jurisdiction

Patent Number

Date of Patent

June 8, 2010

Patent Application Number

11520520

Date Filed

September 13, 2006

Patent Citations Received

Patent Primary Examiner

Patent abstract

The present invention is directed to compounds that are useful for treating cancer having one of the following Formulas:

No Timeline data yet.

Title

Author

Link

Type

Date

No Further Resources data yet.

Find more entities like US Patent 7732613 Met kinase inhibitors

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.